Materiały źródłowe

• #1 Epidemiology of cancer – Wikipedia

  https://en.wikipedia.org/wiki/Epidemiology_of_cancer

  In 2008, cancer was responsible for 25% of all US deaths, with 30% of these from lung cancer. In 2008, the most commonly occurring cancer in men was prostate cancer, at about 25% of new cases. In 2008, amongst women, breast cancer was the most commonly occurring cancer, with about 25% of cancer diagnoses. […] In 2003, in the developed world, one in three people developed cancer during their lifetimes. If all cancer patients survived and cancer occurred randomly, the normal lifetime odds of developing a second primary cancer (not the first cancer spreading to a new site) would be one in nine. However, cancer survivors have an increased risk of developing a second primary cancer, and the odds in 2003 were about one in 4.5.

• #2 Cancer Population Science | Herbert Irving Comprehensive Cancer Center (HICCC) – New York

  https://www.cancer.columbia.edu/research/programs/cancer-population-science

  Aimed at reducing the burden from cancer on a population level, the Cancer Population Science (CPS) Program is conducting observational and interventional studies that focus on primary prevention, early detection, health outcomes and the delivery of cancer care to diverse communities. […] Cancer is a major burden on society in the United States and across the world. In 2018, an estimated 1.7 million new cases of cancer will be diagnosed in the United States over 600,000 people will die from the disease. […] According to the National Cancer Institute, the estimated national expenditures for cancer care in the United States in 2017 were $147.3 billion and costs are likely to increase. […] While cancer affects all population groups, the disease may have a larger or more severe impact on some groups over others, and understanding and addressing these health disparities remains crucial.

• #3 Epidemiology of cancer – Wikipedia

  https://en.wikipedia.org/wiki/Epidemiology_of_cancer

  In 2008, cancer was responsible for 25% of all US deaths, with 30% of these from lung cancer. In 2008, the most commonly occurring cancer in men was prostate cancer, at about 25% of new cases. In 2008, amongst women, breast cancer was the most commonly occurring cancer, with about 25% of cancer diagnoses. […] In 2003, in the developed world, one in three people developed cancer during their lifetimes. If all cancer patients survived and cancer occurred randomly, the normal lifetime odds of developing a second primary cancer (not the first cancer spreading to a new site) would be one in nine. However, cancer survivors have an increased risk of developing a second primary cancer, and the odds in 2003 were about one in 4.5.

• #4 Bladder Cancer: Practice Essentials, Background, Anatomy

  https://emedicine.medscape.com/article/458825-overview

  The American Cancer Society estimates that 84,870 new cases of bladder cancer will be diagnosed in the United States in 2025 and that 17,420 people will die of the disease. The incidence of bladder cancer increases with age, with the median age at diagnosis being 73 years; bladder cancer is rarely diagnosed before age 40 years. Bladder cancer is about 4 times more common in men than in women. The male predominance in bladder cancer in the United States reflects the prevalence of urothelial carcinoma (transitional cell carcinoma). With small cell carcinoma in contrast to urothelial carcinoma the male-to-female incidence ratio is 1:2. […] Worldwide, bladder cancer is diagnosed in approximately 275,000 people each year, and about 108,000 die of this disease. In industrialized countries, 90% of bladder cancers are urothelial carcinomas. In developing countries particularly in the Middle East and Africa the majority of bladder cancers are SCCs, and most of these cancers are secondary to Schistosoma haematobium infection. Urothelial carcinoma is reported to be the most common urologic cancer in China.

• #5 Bladder Cancer: Practice Essentials, Background, Anatomy

  https://emedicine.medscape.com/article/458825-overview

  The American Cancer Society estimates that 84,870 new cases of bladder cancer will be diagnosed in the United States in 2025 and that 17,420 people will die of the disease. The incidence of bladder cancer increases with age, with the median age at diagnosis being 73 years; bladder cancer is rarely diagnosed before age 40 years. Bladder cancer is about 4 times more common in men than in women. The male predominance in bladder cancer in the United States reflects the prevalence of urothelial carcinoma (transitional cell carcinoma). With small cell carcinoma in contrast to urothelial carcinoma the male-to-female incidence ratio is 1:2. […] Worldwide, bladder cancer is diagnosed in approximately 275,000 people each year, and about 108,000 die of this disease. In industrialized countries, 90% of bladder cancers are urothelial carcinomas. In developing countries particularly in the Middle East and Africa the majority of bladder cancers are SCCs, and most of these cancers are secondary to Schistosoma haematobium infection. Urothelial carcinoma is reported to be the most common urologic cancer in China.

• #6 Bladder Cancer: Practice Essentials, Background, Anatomy

  https://emedicine.medscape.com/article/458825-overview

  The American Cancer Society estimates that 84,870 new cases of bladder cancer will be diagnosed in the United States in 2025 and that 17,420 people will die of the disease. The incidence of bladder cancer increases with age, with the median age at diagnosis being 73 years; bladder cancer is rarely diagnosed before age 40 years. Bladder cancer is about 4 times more common in men than in women. The male predominance in bladder cancer in the United States reflects the prevalence of urothelial carcinoma (transitional cell carcinoma). With small cell carcinoma in contrast to urothelial carcinoma the male-to-female incidence ratio is 1:2. […] Worldwide, bladder cancer is diagnosed in approximately 275,000 people each year, and about 108,000 die of this disease. In industrialized countries, 90% of bladder cancers are urothelial carcinomas. In developing countries particularly in the Middle East and Africa the majority of bladder cancers are SCCs, and most of these cancers are secondary to Schistosoma haematobium infection. Urothelial carcinoma is reported to be the most common urologic cancer in China.

• #7 CDC’s Public Health Surveillance of Cancer

  https://www.cdc.gov/pcd/issues/2017/16_0480.htm

  Routine data collection efforts are a necessary, often underappreciated, component of nearly all cancer research and prevention efforts. Public health cancer surveillance data are crucial for identifying needs, planning interventions, directing public health resources, and evaluating the overall effectiveness of initiatives aimed at preventing or treating cancer and its negative health consequences. […] Cancer is the second leading cause of death in the United States and therefore a focus of public health efforts. One defining feature of the public health approach to cancer control is its reliance on population data for planning and evaluating efforts aimed at preventing the health consequences of cancer. […] The World Health Organization defines public health surveillance as the continuous, systematic collection, analysis, and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice.

• #8 Cancer Surveillance Opportunities to Meet Prevention and Control Challenges

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8634486/

  News from the latest Annual Report to the Nation of the Status of Cancer by Islami et al. (1) is largely positive. Cancer mortality overall continues to decrease; for most cancers, incidence is also decreasing. […] Cancer surveillance programs, giving rise to the data in this annual report jointly issued by the Centers for Disease Control and Prevention, the North American Association of Central Cancer Registries, the American Cancer Society, and the National Cancer Institute, are unique in their truly universal, population-based coverage. […] Cancer surveillance is a fundamental tool in our battle to reduce the burden of cancer. The annual reports allow us not only to track progress and measure successes but also to identify problem areas. Being responsive to these identified areas of interest would enable surveillance programs to further meet the needs of all those interested in cancer prevention and control, including clinicians, public health program developers, researchers, and policy makers.

• #9 CDC’s Public Health Surveillance of Cancer

  https://www.cdc.gov/pcd/issues/2017/16_0480.htm

  Routine data collection efforts are a necessary, often underappreciated, component of nearly all cancer research and prevention efforts. Public health cancer surveillance data are crucial for identifying needs, planning interventions, directing public health resources, and evaluating the overall effectiveness of initiatives aimed at preventing or treating cancer and its negative health consequences. […] Cancer is the second leading cause of death in the United States and therefore a focus of public health efforts. One defining feature of the public health approach to cancer control is its reliance on population data for planning and evaluating efforts aimed at preventing the health consequences of cancer. […] The World Health Organization defines public health surveillance as the continuous, systematic collection, analysis, and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice.

• #10 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Cancer surveillance is the ongoing, timely, and systematic collection and analysis of information on new cancer cases, extent of disease, screening tests, treatment, survival, and cancer deaths. […] This cancer information (data) can be used to look for trends over time, to find cancer patterns in certain regions or groups of people, and/or to show whether screening and other prevention measures are making a difference. […] Registries and surveillance information are key parts of cancer prevention and control efforts. […] No single surveillance program in the United States collects data on all cancers diagnosed each year. […] These programs are built on a foundation of existing cancer registries or registries that are set up throughout the country to record and report cancer cases in the areas they cover.

• #11 Cancer Surveillance and Health Services Research (SHSR) | American Cancer Society

  https://www.cancer.org/research/surveillance-and-health-equity-science/surveillance-research.html

  Identify and track emerging trends and inequalities in cancer occurrence and outcomes. […] Contribute to the advancement of surveillance research through scientific publications, conference participation, and collaborations across institutions and disciplines. […] Each year, we produce the ACS flagship report, Cancer Facts Figures, along with its companion article, Cancer Statistics, published in the ACS scientific journal CA: A Cancer Journal for Clinicians. […] These widely cited reports present the most current rates and trends in cancer incidence, mortality, and survival, as well as the most up-to-date information on symptoms, prevention, early detection, and treatment. […] The Surveillance team analyzes and interprets data to produce the ACS Facts Figures. Find the latest information including the most current trends in cancer occurrence survival, as well as information on prevention, early detection, treatment. […] Our team’s epidemiologists regularly update multiple Cancer Facts Figures reports and an interactive statistics website. We also publish additional cancer surveillance research, and we provide statistical support internally and externally.

• #12 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  The magnitude of cancer, for example, varies between countries in terms of types and rates, according to the latest estimates from the International Agency for Research on Cancer (IARC). These international variations in the burden of many cancer types indicate the existence of different carcinogen exposures, highlighting the need for context-specific epidemiological research on cancer aetiology and local policy for prevention and early detection. […] Furthermore, cancer epidemiological analysis has shown a downward trend in cancer rates among older populations; however, an alarming increase in cancer rates among younger adults (aged 50 years) is emerging. […] Identifying the proportion of cancer that can be prevented or the fraction of cancer-related deaths that might be averted due to early detection efforts can empower prevention and awareness campaigns.

• #13 Surveillance, Epidemiology, and End Results – Wikipedia

  https://en.wikipedia.org/wiki/Surveillance,_Epidemiology,_and_End_Results

  The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States. […] SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 45.9% of the population of the United States. […] The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. […] National Cancer Institute funds for the program are combined with funding from the Centers for Disease Control and Prevention (CDC) through the National Program of Cancer Registries and with funding from the involved states. […] Quality control has been an integral part of SEER since its inception.

• #14 Surveillance, Epidemiology, and End Results – Wikipedia

  https://en.wikipedia.org/wiki/Surveillance,_Epidemiology,_and_End_Results

  The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States. […] SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 45.9% of the population of the United States. […] The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. […] National Cancer Institute funds for the program are combined with funding from the Centers for Disease Control and Prevention (CDC) through the National Program of Cancer Registries and with funding from the involved states. […] Quality control has been an integral part of SEER since its inception.

• #15 Surveillance, Epidemiology, and End Results – Wikipedia

  https://en.wikipedia.org/wiki/Surveillance,_Epidemiology,_and_End_Results

  The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States. […] SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 45.9% of the population of the United States. […] The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. […] National Cancer Institute funds for the program are combined with funding from the Centers for Disease Control and Prevention (CDC) through the National Program of Cancer Registries and with funding from the involved states. […] Quality control has been an integral part of SEER since its inception.

• #16 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  The NCI contracts with non-profit organizations to collect data on new cancer diagnoses in the designated geographic locations. […] The National Program of Cancer Registries (NPCR) of the Center for Disease Control and Prevention (CDC) supports population-based registries in state health departments. […] State cancer registries are computerized and have many public health uses. […] Together, the NPCR and the National Cancer Institutes SEER Program collect data for the entire US population. […] Future directions for cancer registries include support of more electronic information sharing.

• #17 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  The NCI contracts with non-profit organizations to collect data on new cancer diagnoses in the designated geographic locations. […] The National Program of Cancer Registries (NPCR) of the Center for Disease Control and Prevention (CDC) supports population-based registries in state health departments. […] State cancer registries are computerized and have many public health uses. […] Together, the NPCR and the National Cancer Institutes SEER Program collect data for the entire US population. […] Future directions for cancer registries include support of more electronic information sharing.

• #18 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  CSU compiles, estimates, and reports cancer statistics through its flagship projects and databases and through high-impact peer-reviewed publications. The Global Cancer Observatory is an interactive web-based platform that presents global cancer indicators of direct relevance to cancer research and policy, developed via CSUs descriptive research programme. […] CSU has several major lines of research based on the databases held within CSU, including in-depth assessments of the international variations for specific cancer types, quantification of the major risk factors contributing to the current cancer burden worldwide, and a global assessment of the long-term benefits of preventive interventions. […] The International Incidence of Childhood Cancer (IICC) series is a flagship project of CSU, undertaken in collaboration with the IACR, that produces quality-assured incidence data on cancer in children and adolescents, based on collaborations with paediatric and general cancer registries worldwide. CSUs surveillance and research work is increasingly embedded within the GICR programme and linked to the continuing efforts of the WHO Global Initiative for Childhood Cancer.

• #19 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  CSU informs global, regional, and national priorities for cancer control action via dedicated programmes of work in six complementary areas. […] CSU provides the Secretariat for the International Association of Cancer Registries (IACR), the professional society dedicated to fostering the aims and activities of cancer registries worldwide. This direct link to registries remains vital to CSUs remit of expanding the availability of quality-assured cancer data. The joint IARCIACR Cancer Incidence in Five Continents series is a flagship publication that compiles comparable cancer incidence rates across diverse registry populations worldwide. […] The Global Initiative for Cancer Registry Development (GICR) aims to markedly increase the coverage, quality, and use of data from PBCRs in low- and middle-income countries. Coordinated by IARC, the GICR brings together major international and national agencies committed to working collaboratively to improve cancer surveillance worldwide.

• #20 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Cancer surveillance is the ongoing, timely, and systematic collection and analysis of information on new cancer cases, extent of disease, screening tests, treatment, survival, and cancer deaths. […] This cancer information (data) can be used to look for trends over time, to find cancer patterns in certain regions or groups of people, and/or to show whether screening and other prevention measures are making a difference. […] Registries and surveillance information are key parts of cancer prevention and control efforts. […] No single surveillance program in the United States collects data on all cancers diagnosed each year. […] These programs are built on a foundation of existing cancer registries or registries that are set up throughout the country to record and report cancer cases in the areas they cover.

• #21 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Population-based registries in cities and states collect and pull together information from multiple reporting facilities within their geographic regions that can include: Hospitals, Doctors offices, Nursing homes, Pathology laboratories, Ambulatory care facilities or clinics, Radiation and chemotherapy treatment centers, Other cancer care facilities. […] These registries provide data that can show things like new cancer cases (incidence) and death rates (mortality) across regions of the country. […] Information from cancer registries helps guide cancer prevention and control programs that are focused on changing certain behaviors (like smoking) and reducing other environmental risks. […] The National Cancer Data Base (NCDB) is a joint program of hospital registries of the Commission on Cancer (COC) and the American Cancer Society.

• #22 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Cancer surveillance is the ongoing, timely, and systematic collection and analysis of information on new cancer cases, extent of disease, screening tests, treatment, survival, and cancer deaths. […] This cancer information (data) can be used to look for trends over time, to find cancer patterns in certain regions or groups of people, and/or to show whether screening and other prevention measures are making a difference. […] Registries and surveillance information are key parts of cancer prevention and control efforts. […] No single surveillance program in the United States collects data on all cancers diagnosed each year. […] These programs are built on a foundation of existing cancer registries or registries that are set up throughout the country to record and report cancer cases in the areas they cover.

• #23 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Population-based registries in cities and states collect and pull together information from multiple reporting facilities within their geographic regions that can include: Hospitals, Doctors offices, Nursing homes, Pathology laboratories, Ambulatory care facilities or clinics, Radiation and chemotherapy treatment centers, Other cancer care facilities. […] These registries provide data that can show things like new cancer cases (incidence) and death rates (mortality) across regions of the country. […] Information from cancer registries helps guide cancer prevention and control programs that are focused on changing certain behaviors (like smoking) and reducing other environmental risks. […] The National Cancer Data Base (NCDB) is a joint program of hospital registries of the Commission on Cancer (COC) and the American Cancer Society.

• #24 Cancer Surveillance System (CSS) | Fred Hutchinson Cancer Center

  https://www.fredhutch.org/en/research/divisions/public-health-sciences-division/research/epidemiology/cancer-surveillance-system.html

  In 1974, the U.S. National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program funded the Fred Hutch to establish the Cancer Surveillance System (CSS). Our mission is to provide high quality data on the incidence, treatment and follow-up of all newly-diagnosed cancers (except non-melanoma skin cancers) in 13 western Washington State counties. […] The collected data helps public health scientists and practitioners: Track trends in the incidence of all forms of cancer (surveillance) […] Identify and investigate patterns of cancer occurrence (epidemiology) […] Monitor trends in mortality and survival for specific cancers (end results). […] The Surveillance, Epidemiology and End Results (SEER) program has been a trusted source for high quality data since 1973. It currently monitors cancer incidence and survival in approximately 34% of the U.S. population.

• #25 Cancer Surveillance Program

  https://csp.usc.edu/

  The Los Angeles Cancer Surveillance Programs mission is to reduce the burden of cancer through monitoring and identifying cancer disparities through innovation and support to the California Cancer Registry and global cancer community and to deliver high quality complete and robust data to reduce morbidity and mortality while improving cancer care in all populations. […] The Los Angeles County Cancer Surveillance Program (CSP) is the population-based cancer registry for Los Angeles County. Since 1972, the CSP has routinely collected and analyzed information on all new cancer diagnoses made among residents of the County. The CSP is a member of the statewide population-based cancer surveillance system, the California Cancer Registry (CCR). It is also part of the National Cancer Institute-funded Surveillance, Epidemiology, and End Results SEER program. The CSP is administered by the University of Southern California (USC) Keck School of Medicine and the USC/Norris Comprehensive Cancer Center. With the large and diverse population of Los Angeles County, the CSP has served as a resource for many epidemiological studies of cancer in Los Angeles County.

• #26 Surveillance, Epidemiology, and End Results – Wikipedia

  https://en.wikipedia.org/wiki/Surveillance,_Epidemiology,_and_End_Results

  The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States. […] SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 45.9% of the population of the United States. […] The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. […] National Cancer Institute funds for the program are combined with funding from the Centers for Disease Control and Prevention (CDC) through the National Program of Cancer Registries and with funding from the involved states. […] Quality control has been an integral part of SEER since its inception.

• #27 Surveillance, Epidemiology, and End Results Program (SEER) – Healthy People 2030 | odphp.health.gov

  https://odphp.health.gov/healthypeople/objectives-and-data/data-sources-and-methods/data-sources/surveillance-epidemiology-and-end-results-program-seer

  Surveillance, Epidemiology, and End Results Program (SEER) tracks the incidence of persons diagnosed with cancer during the year and collects follow-up information on all previously diagnosed patients until their death. […] SEER registries cover 36.7 percent of the U.S. Population. […] The completeness standard for malignant primary tumors is 98 percent or greater. […] Not all states are represented. Only certain metropolitan areas are represented. SEER registries are selected to represent US demographic groups, with oversampling for African Americans, Hispanic, and Asian Pacific Islanders.

• #28 Surveillance, Epidemiology, and End Results Program (SEER) – Healthy People 2030 | odphp.health.gov

  https://odphp.health.gov/healthypeople/objectives-and-data/data-sources-and-methods/data-sources/surveillance-epidemiology-and-end-results-program-seer

  Surveillance, Epidemiology, and End Results Program (SEER) tracks the incidence of persons diagnosed with cancer during the year and collects follow-up information on all previously diagnosed patients until their death. […] SEER registries cover 36.7 percent of the U.S. Population. […] The completeness standard for malignant primary tumors is 98 percent or greater. […] Not all states are represented. Only certain metropolitan areas are represented. SEER registries are selected to represent US demographic groups, with oversampling for African Americans, Hispanic, and Asian Pacific Islanders.

• #29 Michigan Cancer Surveillance Program

  https://www.michigan.gov/mdhhs/doing-business/providers/forms/michigan-cancer-surveillance-program

  In 2022, the North American Association of Central Cancer Registries (NAACCR) awarded Gold Certification to the Michigan Cancer Surveillance Program for quality, completeness, and timeliness of 2019 cancer data. […] We are pleased to announce that the Michigan Cancer Surveillance Program has been named as a Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR) Registry of Distinction for 2022. This distinction recognizes MCSP for providing high-quality data for cancer prevention and control activities at the local, regional, and national levels.

• #30 Michigan Cancer Surveillance Program

  https://www.michigan.gov/mdhhs/doing-business/providers/forms/michigan-cancer-surveillance-program

  In 2022, the North American Association of Central Cancer Registries (NAACCR) awarded Gold Certification to the Michigan Cancer Surveillance Program for quality, completeness, and timeliness of 2019 cancer data. […] We are pleased to announce that the Michigan Cancer Surveillance Program has been named as a Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR) Registry of Distinction for 2022. This distinction recognizes MCSP for providing high-quality data for cancer prevention and control activities at the local, regional, and national levels.

• #31 How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology | Military Medical Research | Full Text

  https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00488-2

  In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. […] The SEER program collects demographic, clinical, and outcome data on all malignancies diagnosed in representative geographic regions and subpopulations in the US. […] One of the main targets of the SEER program is to record cancer incidences and mortality rates for the entire US population. […] The SEER database can also be used in observational studies and national and local public health programs that could promote health through the prevention and control of diseases. […] More than 17,000 articles published from 1973 to 2020 used the SEER database as the primary source of data, and more than 86,000 articles referenced SEER in their studies. […] The SEER program currently records information on around 400,000 cancer cases annually. The volume of SEER data has been growing fast. […] The effective use of the SEER database for cancer research depends on the appropriate application of study designs and statistical models.

• #32 How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology | Military Medical Research | Full Text

  https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00488-2

  In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. […] The SEER program collects demographic, clinical, and outcome data on all malignancies diagnosed in representative geographic regions and subpopulations in the US. […] One of the main targets of the SEER program is to record cancer incidences and mortality rates for the entire US population. […] The SEER database can also be used in observational studies and national and local public health programs that could promote health through the prevention and control of diseases. […] More than 17,000 articles published from 1973 to 2020 used the SEER database as the primary source of data, and more than 86,000 articles referenced SEER in their studies. […] The SEER program currently records information on around 400,000 cancer cases annually. The volume of SEER data has been growing fast. […] The effective use of the SEER database for cancer research depends on the appropriate application of study designs and statistical models.

• #33 How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology | Military Medical Research | Full Text

  https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00488-2

  In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. […] The SEER program collects demographic, clinical, and outcome data on all malignancies diagnosed in representative geographic regions and subpopulations in the US. […] One of the main targets of the SEER program is to record cancer incidences and mortality rates for the entire US population. […] The SEER database can also be used in observational studies and national and local public health programs that could promote health through the prevention and control of diseases. […] More than 17,000 articles published from 1973 to 2020 used the SEER database as the primary source of data, and more than 86,000 articles referenced SEER in their studies. […] The SEER program currently records information on around 400,000 cancer cases annually. The volume of SEER data has been growing fast. […] The effective use of the SEER database for cancer research depends on the appropriate application of study designs and statistical models.

• #34 How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology | Military Medical Research | Full Text

  https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00488-2

  In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. […] The SEER program collects demographic, clinical, and outcome data on all malignancies diagnosed in representative geographic regions and subpopulations in the US. […] One of the main targets of the SEER program is to record cancer incidences and mortality rates for the entire US population. […] The SEER database can also be used in observational studies and national and local public health programs that could promote health through the prevention and control of diseases. […] More than 17,000 articles published from 1973 to 2020 used the SEER database as the primary source of data, and more than 86,000 articles referenced SEER in their studies. […] The SEER program currently records information on around 400,000 cancer cases annually. The volume of SEER data has been growing fast. […] The effective use of the SEER database for cancer research depends on the appropriate application of study designs and statistical models.

• #35 How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology | Military Medical Research | Full Text

  https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00488-2

  In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. […] The SEER program collects demographic, clinical, and outcome data on all malignancies diagnosed in representative geographic regions and subpopulations in the US. […] One of the main targets of the SEER program is to record cancer incidences and mortality rates for the entire US population. […] The SEER database can also be used in observational studies and national and local public health programs that could promote health through the prevention and control of diseases. […] More than 17,000 articles published from 1973 to 2020 used the SEER database as the primary source of data, and more than 86,000 articles referenced SEER in their studies. […] The SEER program currently records information on around 400,000 cancer cases annually. The volume of SEER data has been growing fast. […] The effective use of the SEER database for cancer research depends on the appropriate application of study designs and statistical models.

• #36 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  CSU informs global, regional, and national priorities for cancer control action via dedicated programmes of work in six complementary areas. […] CSU provides the Secretariat for the International Association of Cancer Registries (IACR), the professional society dedicated to fostering the aims and activities of cancer registries worldwide. This direct link to registries remains vital to CSUs remit of expanding the availability of quality-assured cancer data. The joint IARCIACR Cancer Incidence in Five Continents series is a flagship publication that compiles comparable cancer incidence rates across diverse registry populations worldwide. […] The Global Initiative for Cancer Registry Development (GICR) aims to markedly increase the coverage, quality, and use of data from PBCRs in low- and middle-income countries. Coordinated by IARC, the GICR brings together major international and national agencies committed to working collaboratively to improve cancer surveillance worldwide.

• #37 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  The magnitude of cancer, for example, varies between countries in terms of types and rates, according to the latest estimates from the International Agency for Research on Cancer (IARC). These international variations in the burden of many cancer types indicate the existence of different carcinogen exposures, highlighting the need for context-specific epidemiological research on cancer aetiology and local policy for prevention and early detection. […] Furthermore, cancer epidemiological analysis has shown a downward trend in cancer rates among older populations; however, an alarming increase in cancer rates among younger adults (aged 50 years) is emerging. […] Identifying the proportion of cancer that can be prevented or the fraction of cancer-related deaths that might be averted due to early detection efforts can empower prevention and awareness campaigns.

• #38 Cancer Surveillance and Health Services Research (SHSR) | American Cancer Society

  https://www.cancer.org/research/surveillance-and-health-equity-science/surveillance-research.html

  Identify and track emerging trends and inequalities in cancer occurrence and outcomes. […] Contribute to the advancement of surveillance research through scientific publications, conference participation, and collaborations across institutions and disciplines. […] Each year, we produce the ACS flagship report, Cancer Facts Figures, along with its companion article, Cancer Statistics, published in the ACS scientific journal CA: A Cancer Journal for Clinicians. […] These widely cited reports present the most current rates and trends in cancer incidence, mortality, and survival, as well as the most up-to-date information on symptoms, prevention, early detection, and treatment. […] The Surveillance team analyzes and interprets data to produce the ACS Facts Figures. Find the latest information including the most current trends in cancer occurrence survival, as well as information on prevention, early detection, treatment. […] Our team’s epidemiologists regularly update multiple Cancer Facts Figures reports and an interactive statistics website. We also publish additional cancer surveillance research, and we provide statistical support internally and externally.

• #39 Cancer Surveillance and Health Services Research (SHSR) | American Cancer Society

  https://www.cancer.org/research/surveillance-and-health-equity-science/surveillance-research.html

  Identify and track emerging trends and inequalities in cancer occurrence and outcomes. […] Contribute to the advancement of surveillance research through scientific publications, conference participation, and collaborations across institutions and disciplines. […] Each year, we produce the ACS flagship report, Cancer Facts Figures, along with its companion article, Cancer Statistics, published in the ACS scientific journal CA: A Cancer Journal for Clinicians. […] These widely cited reports present the most current rates and trends in cancer incidence, mortality, and survival, as well as the most up-to-date information on symptoms, prevention, early detection, and treatment. […] The Surveillance team analyzes and interprets data to produce the ACS Facts Figures. Find the latest information including the most current trends in cancer occurrence survival, as well as information on prevention, early detection, treatment. […] Our team’s epidemiologists regularly update multiple Cancer Facts Figures reports and an interactive statistics website. We also publish additional cancer surveillance research, and we provide statistical support internally and externally.

• #40 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  Population-based registries in cities and states collect and pull together information from multiple reporting facilities within their geographic regions that can include: Hospitals, Doctors offices, Nursing homes, Pathology laboratories, Ambulatory care facilities or clinics, Radiation and chemotherapy treatment centers, Other cancer care facilities. […] These registries provide data that can show things like new cancer cases (incidence) and death rates (mortality) across regions of the country. […] Information from cancer registries helps guide cancer prevention and control programs that are focused on changing certain behaviors (like smoking) and reducing other environmental risks. […] The National Cancer Data Base (NCDB) is a joint program of hospital registries of the Commission on Cancer (COC) and the American Cancer Society.

• #41 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  The magnitude of cancer, for example, varies between countries in terms of types and rates, according to the latest estimates from the International Agency for Research on Cancer (IARC). These international variations in the burden of many cancer types indicate the existence of different carcinogen exposures, highlighting the need for context-specific epidemiological research on cancer aetiology and local policy for prevention and early detection. […] Furthermore, cancer epidemiological analysis has shown a downward trend in cancer rates among older populations; however, an alarming increase in cancer rates among younger adults (aged 50 years) is emerging. […] Identifying the proportion of cancer that can be prevented or the fraction of cancer-related deaths that might be averted due to early detection efforts can empower prevention and awareness campaigns.

• #42 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  The magnitude of cancer, for example, varies between countries in terms of types and rates, according to the latest estimates from the International Agency for Research on Cancer (IARC). These international variations in the burden of many cancer types indicate the existence of different carcinogen exposures, highlighting the need for context-specific epidemiological research on cancer aetiology and local policy for prevention and early detection. […] Furthermore, cancer epidemiological analysis has shown a downward trend in cancer rates among older populations; however, an alarming increase in cancer rates among younger adults (aged 50 years) is emerging. […] Identifying the proportion of cancer that can be prevented or the fraction of cancer-related deaths that might be averted due to early detection efforts can empower prevention and awareness campaigns.

• #43 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  For years, the European Code Against Cancer has simplified epidemiological studies findings on risk factors, so that individual actions can be taken to help prevent cancer. […] This campaign was built on the fact that 40% of cancer cases can be prevented and another 40% of cancer-related deaths can be prevented if cancer is detected earlier. […] Epidemiologists work alongside biostatisticians and clinicians in assessing new drugs and other oncology-related technologies in terms of both benefits and risks, helping patients and clinicians make informed decisions and policymakers assess the cost-effectiveness of these new products in cancer control.

• #44 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  For years, the European Code Against Cancer has simplified epidemiological studies findings on risk factors, so that individual actions can be taken to help prevent cancer. […] This campaign was built on the fact that 40% of cancer cases can be prevented and another 40% of cancer-related deaths can be prevented if cancer is detected earlier. […] Epidemiologists work alongside biostatisticians and clinicians in assessing new drugs and other oncology-related technologies in terms of both benefits and risks, helping patients and clinicians make informed decisions and policymakers assess the cost-effectiveness of these new products in cancer control.

• #45 Enabling 21st Century Applications for Cancer Surveillance through Enhanced Registries and Beyond A Workshop | National Academies

  https://www.nationalacademies.org/our-work/enabling-21st-century-applications-for-cancer-surveillance-through-enhanced-registries-and-beyond-a-workshop

  On July 29 and 30, 2024, a planning committee of the National Academies of Sciences, Engineering, and Medicine will organize a public workshop that will examine challenges with the current US system of cancer surveillance, as well as potential opportunities to modernize cancer surveillance programs to facilitate improvements in cancer research and cancer care. […] Population-based cancer surveillance has a pivotal role in assessing the nation’s progress in cancer control and helps inform research and care interventions aimed at reducing the burden of cancer on patients and communities, including the ability to identify health disparities in cancer outcomes. However, challenges with the current approach to cancer surveillance in the United States include delays and gaps in data collection, as well as inadequate infrastructure and workforce to keep pace with the informatics and treatment-related advances in cancer.

• #46 Enabling 21st Century Applications for Cancer Surveillance through Enhanced Registries and Beyond A Workshop | National Academies

  https://www.nationalacademies.org/our-work/enabling-21st-century-applications-for-cancer-surveillance-through-enhanced-registries-and-beyond-a-workshop

  On July 29 and 30, 2024, a planning committee of the National Academies of Sciences, Engineering, and Medicine will organize a public workshop that will examine challenges with the current US system of cancer surveillance, as well as potential opportunities to modernize cancer surveillance programs to facilitate improvements in cancer research and cancer care. […] Population-based cancer surveillance has a pivotal role in assessing the nation’s progress in cancer control and helps inform research and care interventions aimed at reducing the burden of cancer on patients and communities, including the ability to identify health disparities in cancer outcomes. However, challenges with the current approach to cancer surveillance in the United States include delays and gaps in data collection, as well as inadequate infrastructure and workforce to keep pace with the informatics and treatment-related advances in cancer.

• #47 Enabling 21st Century Applications for Cancer Surveillance through Enhanced Registries and Beyond A Workshop | National Academies

  https://www.nationalacademies.org/our-work/enabling-21st-century-applications-for-cancer-surveillance-through-enhanced-registries-and-beyond-a-workshop

  The workshop will feature invited presentations and panel discussions on topics that may include: Importance of population-based surveillance to understand and address health disparities and identify opportunities to improve the quality of cancer care. […] The current landscape of US cancer surveillance efforts (e.g., National Program of Cancer Registries, Surveillance, Epidemiology and End Results Program, National Cancer Database of the Commission on Cancer, as well as other hospital and population-based cancer registries). […] Possible strategies and innovations to address challenges with existing cancer surveillance infrastructure, workforce, data collection methodologies, and data completeness. […] Possible consequences of advances in informatics, cancer treatment, and research that rapidly outpace cancer surveillance infrastructure and methodologies, including challenges with timely assessment of the quality of cancer care and the potential to exacerbate disparities in cancer care and patient outcomes.

• #48 Enabling 21st Century Applications for Cancer Surveillance through Enhanced Registries and Beyond A Workshop | National Academies

  https://www.nationalacademies.org/our-work/enabling-21st-century-applications-for-cancer-surveillance-through-enhanced-registries-and-beyond-a-workshop

  Potential strategies for improving cancer surveillance efforts through interdisciplinary collaboration and lessons learned from other surveillance systems. […] Potential opportunities to modernize cancer surveillance through appropriate use of technologies such as electronic health record systems, artificial intelligence, cloud-based data collection, and data linkages.

• #49 Enabling 21st Century Applications for Cancer Surveillance through Enhanced Registries and Beyond A Workshop | National Academies

  https://www.nationalacademies.org/our-work/enabling-21st-century-applications-for-cancer-surveillance-through-enhanced-registries-and-beyond-a-workshop

  Potential strategies for improving cancer surveillance efforts through interdisciplinary collaboration and lessons learned from other surveillance systems. […] Potential opportunities to modernize cancer surveillance through appropriate use of technologies such as electronic health record systems, artificial intelligence, cloud-based data collection, and data linkages.

• #50 Cancer Surveillance Programs and Registries in the United States | American Cancer Society

  https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/cancer-surveillance-programs-and-registries-in-the-united-states.html

  The NCI contracts with non-profit organizations to collect data on new cancer diagnoses in the designated geographic locations. […] The National Program of Cancer Registries (NPCR) of the Center for Disease Control and Prevention (CDC) supports population-based registries in state health departments. […] State cancer registries are computerized and have many public health uses. […] Together, the NPCR and the National Cancer Institutes SEER Program collect data for the entire US population. […] Future directions for cancer registries include support of more electronic information sharing.

• #51 Cancer Surveillance Informatics | NPCR | CDC

  https://www.cdc.gov/national-program-cancer-registries/data-modernization/informatics.html

  Cancer surveillance informatics focuses on identifying and evaluating how to use emerging technology to incorporate automated processes and electronic data exchange. […] Cancer surveillance informatics projects evaluate data streams, such as insurance claims data that may meet cancer registries’ requirements, alleviating the need to create special data streams for cancer registries. […] The National Program of Cancer Registries provides funds and technical assistance to central cancer registries.

• #52 Cancer Surveillance Informatics | NPCR | CDC

  https://www.cdc.gov/national-program-cancer-registries/data-modernization/informatics.html

  Cancer surveillance informatics focuses on identifying and evaluating how to use emerging technology to incorporate automated processes and electronic data exchange. […] Cancer surveillance informatics projects evaluate data streams, such as insurance claims data that may meet cancer registries’ requirements, alleviating the need to create special data streams for cancer registries. […] The National Program of Cancer Registries provides funds and technical assistance to central cancer registries.

• #53 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  IARC convened an expert workshop of multidisciplinary scientists to identify research priorities for reducing social inequalities in cancer, leading to the production of IARC Scientific Publication No. 168. On this basis, several research projects on social inequalities and cancer have been developed within CSU, including the documentation of social inequalities in cancer between and within countries, with a primary focus on the gradient of the association, as well as temporal and geographical variations. The IARC Cancer Inequalities Team (CIN), led by CSU, seeks to measure, understand, and reduce social inequalities in cancer. […] Building on several collaborative descriptive economic studies within CSU, the aim is to better understand the economic burden of cancer to national economies and health systems as well as to individuals and households.

• #54 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  IARC convened an expert workshop of multidisciplinary scientists to identify research priorities for reducing social inequalities in cancer, leading to the production of IARC Scientific Publication No. 168. On this basis, several research projects on social inequalities and cancer have been developed within CSU, including the documentation of social inequalities in cancer between and within countries, with a primary focus on the gradient of the association, as well as temporal and geographical variations. The IARC Cancer Inequalities Team (CIN), led by CSU, seeks to measure, understand, and reduce social inequalities in cancer. […] Building on several collaborative descriptive economic studies within CSU, the aim is to better understand the economic burden of cancer to national economies and health systems as well as to individuals and households.

• #55 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  IARC convened an expert workshop of multidisciplinary scientists to identify research priorities for reducing social inequalities in cancer, leading to the production of IARC Scientific Publication No. 168. On this basis, several research projects on social inequalities and cancer have been developed within CSU, including the documentation of social inequalities in cancer between and within countries, with a primary focus on the gradient of the association, as well as temporal and geographical variations. The IARC Cancer Inequalities Team (CIN), led by CSU, seeks to measure, understand, and reduce social inequalities in cancer. […] Building on several collaborative descriptive economic studies within CSU, the aim is to better understand the economic burden of cancer to national economies and health systems as well as to individuals and households.

• #56 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  IARC convened an expert workshop of multidisciplinary scientists to identify research priorities for reducing social inequalities in cancer, leading to the production of IARC Scientific Publication No. 168. On this basis, several research projects on social inequalities and cancer have been developed within CSU, including the documentation of social inequalities in cancer between and within countries, with a primary focus on the gradient of the association, as well as temporal and geographical variations. The IARC Cancer Inequalities Team (CIN), led by CSU, seeks to measure, understand, and reduce social inequalities in cancer. […] Building on several collaborative descriptive economic studies within CSU, the aim is to better understand the economic burden of cancer to national economies and health systems as well as to individuals and households.

• #57 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu/

  IARC convened an expert workshop of multidisciplinary scientists to identify research priorities for reducing social inequalities in cancer, leading to the production of IARC Scientific Publication No. 168. On this basis, several research projects on social inequalities and cancer have been developed within CSU, including the documentation of social inequalities in cancer between and within countries, with a primary focus on the gradient of the association, as well as temporal and geographical variations. The IARC Cancer Inequalities Team (CIN), led by CSU, seeks to measure, understand, and reduce social inequalities in cancer. […] Building on several collaborative descriptive economic studies within CSU, the aim is to better understand the economic burden of cancer to national economies and health systems as well as to individuals and households.

• #58 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Dynamic models to predict the long-term future burden under scenarios of roll-out of screening and vaccination programmes. […] Descriptive epidemiology of social inequalities in cancer, including: developing a research and data framework to study socioeconomic inequalities in cancer; integrating indicators into the European Cancer Inequalities Registry; and assessing inequalities in cancer mortality by education, sex, age, and residence. […] Estimate the productivity losses due to cancer-related premature mortality and morbidity from cancer at the global, regional, and national levels. […] Estimate health expenditure costs from cancer across countries. […] Estimate informal health-care costs for cancer at the global, regional, and national levels. […] Perform priority-setting in cancer prevention and control. Collaborations with WHO and partners to assist national policy-makers to obtain the best value for money by identifying priority interventions in cancer planning and evaluating the impact, cost, and feasibility of a package of interventions according to country capacity. […] The GICR was established to coordinate activities that increase the quality, availability, and use of cancer data worldwide.

• #59 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  Tomi Akinyemiju, PhD, is a professor in the Department of Population Health Sciences. She believes epidemiologists have a professional and moral imperative to ensure that medical and policy solutions are equitably applied to all populations. […] We need a lot more emphasis on prevention and health equity. […] In terms of prevention, the future of epidemiology is more personalized approaches tailored to each individuals unique context. […] In terms of risk prediction, the future of epidemiology is leveraging big data and tools like AI and machine learning for complex analyses on millions of data points. […] Even when we have interventions that work perfectly, we have to make sure there is equitable access to that knowledge and insight. In the United States, health equity remains a problem.

• #60 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  The future of epidemiology must consider that health risks are not distributed equally. Certain communities are more exposed to health risks like environmental exposures to toxic waste or are more heavily impacted by climate change or infection, as we saw with COVID-19. […] As the major health care provider in Durham, Duke has an obligation to address the health concerns in our backyard.

• #61 High-Risk Cancer Surveillance Clinic | Overlake Medical Center & Clinics

  https://www.overlakehospital.org/services/cancer-care/High-Risk-Cancer-Surveillance-Clinic

  At the Overlake High-Risk Cancer Surveillance Clinic, we are committed to providing specialized care for individuals at elevated risk of developing cancer. […] Our mission is to empower individuals with a high family or genetic predisposition to cancer by offering comprehensive risk assessment, genetic testing, counseling and proactive care plans. […] If you are at increased risk for cancer, taking advantage of additional screening options may detect cancer at an earlier stage or decrease your risk for ever developing cancer in the first place. […] Surveillance and prevention are vital for anyone at a higher risk for hereditary cancers including breast, ovarian, gastric, colorectal, pancreatic, melanoma, endometrial and prostate cancers. […] Early detection is critical in high-risk individuals.

• #62 High-Risk Cancer Surveillance Clinic | Overlake Medical Center & Clinics

  https://www.overlakehospital.org/services/cancer-care/High-Risk-Cancer-Surveillance-Clinic

  At the Overlake High-Risk Cancer Surveillance Clinic, we are committed to providing specialized care for individuals at elevated risk of developing cancer. […] Our mission is to empower individuals with a high family or genetic predisposition to cancer by offering comprehensive risk assessment, genetic testing, counseling and proactive care plans. […] If you are at increased risk for cancer, taking advantage of additional screening options may detect cancer at an earlier stage or decrease your risk for ever developing cancer in the first place. […] Surveillance and prevention are vital for anyone at a higher risk for hereditary cancers including breast, ovarian, gastric, colorectal, pancreatic, melanoma, endometrial and prostate cancers. […] Early detection is critical in high-risk individuals.

• #63 High-Risk Cancer Surveillance Clinic | Overlake Medical Center & Clinics

  https://www.overlakehospital.org/services/cancer-care/High-Risk-Cancer-Surveillance-Clinic

  At the Overlake High-Risk Cancer Surveillance Clinic, we are committed to providing specialized care for individuals at elevated risk of developing cancer. […] Our mission is to empower individuals with a high family or genetic predisposition to cancer by offering comprehensive risk assessment, genetic testing, counseling and proactive care plans. […] If you are at increased risk for cancer, taking advantage of additional screening options may detect cancer at an earlier stage or decrease your risk for ever developing cancer in the first place. […] Surveillance and prevention are vital for anyone at a higher risk for hereditary cancers including breast, ovarian, gastric, colorectal, pancreatic, melanoma, endometrial and prostate cancers. […] Early detection is critical in high-risk individuals.

• #64 High-Risk Cancer Surveillance Clinic | Overlake Medical Center & Clinics

  https://www.overlakehospital.org/services/cancer-care/High-Risk-Cancer-Surveillance-Clinic

  At the Overlake High-Risk Cancer Surveillance Clinic, we are committed to providing specialized care for individuals at elevated risk of developing cancer. […] Our mission is to empower individuals with a high family or genetic predisposition to cancer by offering comprehensive risk assessment, genetic testing, counseling and proactive care plans. […] If you are at increased risk for cancer, taking advantage of additional screening options may detect cancer at an earlier stage or decrease your risk for ever developing cancer in the first place. […] Surveillance and prevention are vital for anyone at a higher risk for hereditary cancers including breast, ovarian, gastric, colorectal, pancreatic, melanoma, endometrial and prostate cancers. […] Early detection is critical in high-risk individuals.

• #65 High-Risk Cancer Surveillance Clinic | Overlake Medical Center & Clinics

  https://www.overlakehospital.org/services/cancer-care/High-Risk-Cancer-Surveillance-Clinic

  At the Overlake High-Risk Cancer Surveillance Clinic, we are committed to providing specialized care for individuals at elevated risk of developing cancer. […] Our mission is to empower individuals with a high family or genetic predisposition to cancer by offering comprehensive risk assessment, genetic testing, counseling and proactive care plans. […] If you are at increased risk for cancer, taking advantage of additional screening options may detect cancer at an earlier stage or decrease your risk for ever developing cancer in the first place. […] Surveillance and prevention are vital for anyone at a higher risk for hereditary cancers including breast, ovarian, gastric, colorectal, pancreatic, melanoma, endometrial and prostate cancers. […] Early detection is critical in high-risk individuals.

• #66 Active Surveillance for Cancer – Regional Cancer Care Associates

  https://www.regionalcancercare.org/services/active-surveillance/

  Active surveillance may be recommended as part of a patients treatment plan. […] Active surveillance is part of a cancer treatment plan and qualifies as a form of expectant management: the process of monitoring early signs and symptoms of certain diseases. […] At Regional Cancer Care Associates, our active surveillance plan comprises state-of-the-art technology and an expert team of oncologists and specialists. […] Compared to other cancer treatments, active surveillance can be extremely beneficial. […] Active surveillance allows many patients to live a normal life while specialists keep a keen eye on their cancers progress. […] Active surveillance has proven to be exceptionally advantageous for men with low-risk prostate cancer. […] Active surveillance allows us to monitor cancer from the start, were able to constantly analyze the diseases effects and progress to determine our next steps before symptoms get worse.

• #67 Active Surveillance for Prostate Cancer | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/prostate/treatment/active-surveillance

  Not all prostate cancers are the same. Some grow quickly and need treatment right away. Others grow slowly and are less likely to metastasize (spread) to other parts of your body. This kind of prostate cancer is low risk. […] If you have a prostate cancer that grows slowly, your healthcare provider may recommend active surveillance. […] Active surveillance is a form of treatment for prostate cancer. Its not the same as having no treatment. […] This treatment option helps people with slow-growing prostate cancer avoid possible side effects of surgery and radiation therapy, including: […] As part of active surveillance, you will have tests every few months to watch for any changes in your prostate. […] Your care team may notice changes in your prostate or tumor at any time during surveillance. If so, they may recommend you stop active surveillance. You may start another type of treatment, such as surgery or radiation therapy.

• #68 Active Surveillance for Prostate Cancer | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/prostate/treatment/active-surveillance

  Not all prostate cancers are the same. Some grow quickly and need treatment right away. Others grow slowly and are less likely to metastasize (spread) to other parts of your body. This kind of prostate cancer is low risk. […] If you have a prostate cancer that grows slowly, your healthcare provider may recommend active surveillance. […] Active surveillance is a form of treatment for prostate cancer. Its not the same as having no treatment. […] This treatment option helps people with slow-growing prostate cancer avoid possible side effects of surgery and radiation therapy, including: […] As part of active surveillance, you will have tests every few months to watch for any changes in your prostate. […] Your care team may notice changes in your prostate or tumor at any time during surveillance. If so, they may recommend you stop active surveillance. You may start another type of treatment, such as surgery or radiation therapy.

• #69 Active Surveillance for Prostate Cancer | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/prostate/treatment/active-surveillance

  Active surveillance can be the right choice for people with low-risk prostate cancers. Its a treatment option that matches how harmful the cancer is. […] During active surveillance, youll have tests every few months to look for any changes in your prostate. […] Your care team will use the results from these tests to monitor the cancer. […] Research shows that active surveillance is a safe treatment for people with low-risk cancers. […] Your care team monitors the cancer closely. They look for important changes to your prostate. If the cancer grows or spreads, your care team will know in time to take action. […] Yes. We cannot predict who will have prostate cancer that gets worse or needs treatment in the future. But we know its unlikely we will miss a change in the cancer if you follow your active surveillance schedule.

• #70 Active Surveillance for Cancer – Regional Cancer Care Associates

  https://www.regionalcancercare.org/services/active-surveillance/

  Active surveillance may be recommended as part of a patients treatment plan. […] Active surveillance is part of a cancer treatment plan and qualifies as a form of expectant management: the process of monitoring early signs and symptoms of certain diseases. […] At Regional Cancer Care Associates, our active surveillance plan comprises state-of-the-art technology and an expert team of oncologists and specialists. […] Compared to other cancer treatments, active surveillance can be extremely beneficial. […] Active surveillance allows many patients to live a normal life while specialists keep a keen eye on their cancers progress. […] Active surveillance has proven to be exceptionally advantageous for men with low-risk prostate cancer. […] Active surveillance allows us to monitor cancer from the start, were able to constantly analyze the diseases effects and progress to determine our next steps before symptoms get worse.

• #71 Active Surveillance for Cancer – Regional Cancer Care Associates

  https://www.regionalcancercare.org/services/active-surveillance/

  Active surveillance may be recommended as part of a patients treatment plan. […] Active surveillance is part of a cancer treatment plan and qualifies as a form of expectant management: the process of monitoring early signs and symptoms of certain diseases. […] At Regional Cancer Care Associates, our active surveillance plan comprises state-of-the-art technology and an expert team of oncologists and specialists. […] Compared to other cancer treatments, active surveillance can be extremely beneficial. […] Active surveillance allows many patients to live a normal life while specialists keep a keen eye on their cancers progress. […] Active surveillance has proven to be exceptionally advantageous for men with low-risk prostate cancer. […] Active surveillance allows us to monitor cancer from the start, were able to constantly analyze the diseases effects and progress to determine our next steps before symptoms get worse.

• #72 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  CSU is involved in many collaborative studies seeking to describe and interpret the changing magnitude and the transitional nature of cancer profiles around the world, through observation of variations by geography and over time. […] Enhancing understanding of global, regional, national, and subnational changes in cancer risk and survival and their determinants, including in relation to ongoing socioeconomic transitions and social inequalities. […] Generating scientific evidence related to the effectiveness of implementing primary prevention interventions, including the prevention or reduction of exposure to established modifiable risk factors. […] Enhancing understanding of the economic impact of cancer, to ensure equitable and sustainable health systems that are capable of effectively reducing the burden of cancer.

• #73 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  CSU is involved in many collaborative studies seeking to describe and interpret the changing magnitude and the transitional nature of cancer profiles around the world, through observation of variations by geography and over time. […] Enhancing understanding of global, regional, national, and subnational changes in cancer risk and survival and their determinants, including in relation to ongoing socioeconomic transitions and social inequalities. […] Generating scientific evidence related to the effectiveness of implementing primary prevention interventions, including the prevention or reduction of exposure to established modifiable risk factors. […] Enhancing understanding of the economic impact of cancer, to ensure equitable and sustainable health systems that are capable of effectively reducing the burden of cancer.

• #74 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  CSU is involved in many collaborative studies seeking to describe and interpret the changing magnitude and the transitional nature of cancer profiles around the world, through observation of variations by geography and over time. […] Enhancing understanding of global, regional, national, and subnational changes in cancer risk and survival and their determinants, including in relation to ongoing socioeconomic transitions and social inequalities. […] Generating scientific evidence related to the effectiveness of implementing primary prevention interventions, including the prevention or reduction of exposure to established modifiable risk factors. […] Enhancing understanding of the economic impact of cancer, to ensure equitable and sustainable health systems that are capable of effectively reducing the burden of cancer.

• #75 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  CSU is involved in many collaborative studies seeking to describe and interpret the changing magnitude and the transitional nature of cancer profiles around the world, through observation of variations by geography and over time. […] Enhancing understanding of global, regional, national, and subnational changes in cancer risk and survival and their determinants, including in relation to ongoing socioeconomic transitions and social inequalities. […] Generating scientific evidence related to the effectiveness of implementing primary prevention interventions, including the prevention or reduction of exposure to established modifiable risk factors. […] Enhancing understanding of the economic impact of cancer, to ensure equitable and sustainable health systems that are capable of effectively reducing the burden of cancer.

• #76 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  CSU is involved in many collaborative studies seeking to describe and interpret the changing magnitude and the transitional nature of cancer profiles around the world, through observation of variations by geography and over time. […] Enhancing understanding of global, regional, national, and subnational changes in cancer risk and survival and their determinants, including in relation to ongoing socioeconomic transitions and social inequalities. […] Generating scientific evidence related to the effectiveness of implementing primary prevention interventions, including the prevention or reduction of exposure to established modifiable risk factors. […] Enhancing understanding of the economic impact of cancer, to ensure equitable and sustainable health systems that are capable of effectively reducing the burden of cancer.

• #77 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Conduct in-depth monitoring of key indicators of cancer incidence, survival, and mortality during and after future crises linked to pandemics or other major events. […] Explore reasons for disruptions to cancer services and effective mitigation strategies. […] Provide a tool to model the short-, medium-, and long-term impact of disruptions on cancer outcomes, to improve resilience in cancer control. […] Studies quantifying the proportion of cancer cases attributable to risk factors (updates or new factors: body mass index, smoking including smokeless tobacco use, physical inactivity, infectious agents, and ultraviolet radiation). […] Estimation of the burden of cancer using disability-adjusted life years (DALYs). […] Meeting global noncommunicable disease (NCD) targets. Using mortality trends to predict future premature deaths from cancer and other NCDs, as well as the contribution of risk factors and prevention strategies in achieving United Nations Sustainable Development Goals targets.

• #78 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Conduct in-depth monitoring of key indicators of cancer incidence, survival, and mortality during and after future crises linked to pandemics or other major events. […] Explore reasons for disruptions to cancer services and effective mitigation strategies. […] Provide a tool to model the short-, medium-, and long-term impact of disruptions on cancer outcomes, to improve resilience in cancer control. […] Studies quantifying the proportion of cancer cases attributable to risk factors (updates or new factors: body mass index, smoking including smokeless tobacco use, physical inactivity, infectious agents, and ultraviolet radiation). […] Estimation of the burden of cancer using disability-adjusted life years (DALYs). […] Meeting global noncommunicable disease (NCD) targets. Using mortality trends to predict future premature deaths from cancer and other NCDs, as well as the contribution of risk factors and prevention strategies in achieving United Nations Sustainable Development Goals targets.

• #79 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Conduct in-depth monitoring of key indicators of cancer incidence, survival, and mortality during and after future crises linked to pandemics or other major events. […] Explore reasons for disruptions to cancer services and effective mitigation strategies. […] Provide a tool to model the short-, medium-, and long-term impact of disruptions on cancer outcomes, to improve resilience in cancer control. […] Studies quantifying the proportion of cancer cases attributable to risk factors (updates or new factors: body mass index, smoking including smokeless tobacco use, physical inactivity, infectious agents, and ultraviolet radiation). […] Estimation of the burden of cancer using disability-adjusted life years (DALYs). […] Meeting global noncommunicable disease (NCD) targets. Using mortality trends to predict future premature deaths from cancer and other NCDs, as well as the contribution of risk factors and prevention strategies in achieving United Nations Sustainable Development Goals targets.

• #80 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Conduct in-depth monitoring of key indicators of cancer incidence, survival, and mortality during and after future crises linked to pandemics or other major events. […] Explore reasons for disruptions to cancer services and effective mitigation strategies. […] Provide a tool to model the short-, medium-, and long-term impact of disruptions on cancer outcomes, to improve resilience in cancer control. […] Studies quantifying the proportion of cancer cases attributable to risk factors (updates or new factors: body mass index, smoking including smokeless tobacco use, physical inactivity, infectious agents, and ultraviolet radiation). […] Estimation of the burden of cancer using disability-adjusted life years (DALYs). […] Meeting global noncommunicable disease (NCD) targets. Using mortality trends to predict future premature deaths from cancer and other NCDs, as well as the contribution of risk factors and prevention strategies in achieving United Nations Sustainable Development Goals targets.

• #81 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Conduct in-depth monitoring of key indicators of cancer incidence, survival, and mortality during and after future crises linked to pandemics or other major events. […] Explore reasons for disruptions to cancer services and effective mitigation strategies. […] Provide a tool to model the short-, medium-, and long-term impact of disruptions on cancer outcomes, to improve resilience in cancer control. […] Studies quantifying the proportion of cancer cases attributable to risk factors (updates or new factors: body mass index, smoking including smokeless tobacco use, physical inactivity, infectious agents, and ultraviolet radiation). […] Estimation of the burden of cancer using disability-adjusted life years (DALYs). […] Meeting global noncommunicable disease (NCD) targets. Using mortality trends to predict future premature deaths from cancer and other NCDs, as well as the contribution of risk factors and prevention strategies in achieving United Nations Sustainable Development Goals targets.

• #82 Cancer Surveillance Branch (CSU) – IARC

  https://www.iarc.who.int/branches-csu-research/

  Dynamic models to predict the long-term future burden under scenarios of roll-out of screening and vaccination programmes. […] Descriptive epidemiology of social inequalities in cancer, including: developing a research and data framework to study socioeconomic inequalities in cancer; integrating indicators into the European Cancer Inequalities Registry; and assessing inequalities in cancer mortality by education, sex, age, and residence. […] Estimate the productivity losses due to cancer-related premature mortality and morbidity from cancer at the global, regional, and national levels. […] Estimate health expenditure costs from cancer across countries. […] Estimate informal health-care costs for cancer at the global, regional, and national levels. […] Perform priority-setting in cancer prevention and control. Collaborations with WHO and partners to assist national policy-makers to obtain the best value for money by identifying priority interventions in cancer planning and evaluating the impact, cost, and feasibility of a package of interventions according to country capacity. […] The GICR was established to coordinate activities that increase the quality, availability, and use of cancer data worldwide.

• #83 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  Tomi Akinyemiju, PhD, is a professor in the Department of Population Health Sciences. She believes epidemiologists have a professional and moral imperative to ensure that medical and policy solutions are equitably applied to all populations. […] We need a lot more emphasis on prevention and health equity. […] In terms of prevention, the future of epidemiology is more personalized approaches tailored to each individuals unique context. […] In terms of risk prediction, the future of epidemiology is leveraging big data and tools like AI and machine learning for complex analyses on millions of data points. […] Even when we have interventions that work perfectly, we have to make sure there is equitable access to that knowledge and insight. In the United States, health equity remains a problem.

• #84 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  Tomi Akinyemiju, PhD, is a professor in the Department of Population Health Sciences. She believes epidemiologists have a professional and moral imperative to ensure that medical and policy solutions are equitably applied to all populations. […] We need a lot more emphasis on prevention and health equity. […] In terms of prevention, the future of epidemiology is more personalized approaches tailored to each individuals unique context. […] In terms of risk prediction, the future of epidemiology is leveraging big data and tools like AI and machine learning for complex analyses on millions of data points. […] Even when we have interventions that work perfectly, we have to make sure there is equitable access to that knowledge and insight. In the United States, health equity remains a problem.

• #85 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  Tomi Akinyemiju, PhD, is a professor in the Department of Population Health Sciences. She believes epidemiologists have a professional and moral imperative to ensure that medical and policy solutions are equitably applied to all populations. […] We need a lot more emphasis on prevention and health equity. […] In terms of prevention, the future of epidemiology is more personalized approaches tailored to each individuals unique context. […] In terms of risk prediction, the future of epidemiology is leveraging big data and tools like AI and machine learning for complex analyses on millions of data points. […] Even when we have interventions that work perfectly, we have to make sure there is equitable access to that knowledge and insight. In the United States, health equity remains a problem.

• #86 What Comes Next: Cancer Epidemiology and Population Health | Duke University School of Medicine

  https://medschool.duke.edu/news/what-comes-next-cancer-epidemiology-and-population-health

  The future of epidemiology must consider that health risks are not distributed equally. Certain communities are more exposed to health risks like environmental exposures to toxic waste or are more heavily impacted by climate change or infection, as we saw with COVID-19. […] As the major health care provider in Durham, Duke has an obligation to address the health concerns in our backyard.

• #87 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  Epidemiology is the study of how diseases, such as cancer, spread and affect people. As a field, it can offer many opportunities to address challenges facing cancer control policies. […] Over the last 70 years, epidemiology has played a key role in describing the burden of cancer, identifying many of its risk factors, and assessing care outcomes. Evidence generated from epidemiological studies shows that around 40% of all cancer cases could be prevented, and further related deaths could be reduced through early detection and screening. […] One vital aspect of epidemiology is monitoring the magnitude and trends of cancer occurrence through population-based cancer registries, which enables the allocation of future prevention and early detection initiatives, as well as support facilities and manpower planning.

• #88 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  Epidemiology is the study of how diseases, such as cancer, spread and affect people. As a field, it can offer many opportunities to address challenges facing cancer control policies. […] Over the last 70 years, epidemiology has played a key role in describing the burden of cancer, identifying many of its risk factors, and assessing care outcomes. Evidence generated from epidemiological studies shows that around 40% of all cancer cases could be prevented, and further related deaths could be reduced through early detection and screening. […] One vital aspect of epidemiology is monitoring the magnitude and trends of cancer occurrence through population-based cancer registries, which enables the allocation of future prevention and early detection initiatives, as well as support facilities and manpower planning.

• #89 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  Epidemiology is the study of how diseases, such as cancer, spread and affect people. As a field, it can offer many opportunities to address challenges facing cancer control policies. […] Over the last 70 years, epidemiology has played a key role in describing the burden of cancer, identifying many of its risk factors, and assessing care outcomes. Evidence generated from epidemiological studies shows that around 40% of all cancer cases could be prevented, and further related deaths could be reduced through early detection and screening. […] One vital aspect of epidemiology is monitoring the magnitude and trends of cancer occurrence through population-based cancer registries, which enables the allocation of future prevention and early detection initiatives, as well as support facilities and manpower planning.

• #90 How epidemiology can help cancer control efforts and influence policy decisions | UICC

  https://www.uicc.org/news-and-updates/blog/how-epidemiology-can-help-cancer-control-efforts-and-influence-policy

  Epidemiology is the study of how diseases, such as cancer, spread and affect people. As a field, it can offer many opportunities to address challenges facing cancer control policies. […] Over the last 70 years, epidemiology has played a key role in describing the burden of cancer, identifying many of its risk factors, and assessing care outcomes. Evidence generated from epidemiological studies shows that around 40% of all cancer cases could be prevented, and further related deaths could be reduced through early detection and screening. […] One vital aspect of epidemiology is monitoring the magnitude and trends of cancer occurrence through population-based cancer registries, which enables the allocation of future prevention and early detection initiatives, as well as support facilities and manpower planning.

• #91 South Carolina Cancer Surveillance for Population Health Research and Outreach Tool | MUSC Hollings Cancer Center

  https://hollingscancercenter.musc.edu/outreach/sc-spot-south-carolina-cancer-data-statistics

  The South Carolina Cancer Surveillance for Population Health Research and Outreach Tool (SC SPOT) provides cancer-relevant data for all 46 counties in the state. Our goal is to share usable, understandable, and accessible data in order to foster research collaboration, empower communities, and improve health outcomes for all South Carolinians. […] Beyond visualization of cancer cases and deaths, we explore social determinants of health across South Carolina communities and illustrate the distribution of risk factors, health care access, and population sociodemographics. […] Join us on this journey of education, advocacy, and action as we work together towards improving cancer outcomes in South Carolina.

Zobacz więcej